Preventing catheter-related bacteriuria: Should we? Can we? How?

Archives of Internal Medicine

Volumn 159, Issue 8, 1999, Pages 800-808

  Saint, Sanjay ^a,c   Lipsky, Benjamin A ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; METHENAMINE HIPPURATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIURIA; BLADDER IRRIGATION; CATHETERIZATION; CLINICAL PROTOCOL; INFECTION PREVENTION; INFECTION RISK; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRANSURETHRAL RESECTION; TREATMENT INDICATION; URINARY TRACT INFECTION; URINE CATHETER;

ANTI-INFECTIVE AGENTS, URINARY; BACTERIURIA; CATHETERS, INDWELLING; HIPPURATES; HUMANS; METHENAMINE; RISK FACTORS; URINARY CATHETERIZATION;

EID: 0033606112     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.8.800     Document Type: Review

References (103)

1. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am. 1997;11: 609-622.
2. Beeson PB. The case against the catheter. Am J Med. 1958;24:1-3.
3. Catheter-associated urinary-tract infections [editorial]. Lancet. 1978;2:1033-1034.
4. Stark RP, Maki DO. Bacteriuria in the catheterized patient: what quantitative level of bacterium is relevant? N Engl J Med. 1984;311:560-564.
5. Stamm WE. Urinary tract infections. In: Bennett JV, Brachman PS, eds. Hospital Infections. 4th ed. Philadelphia, Pa: Lippincott-Raven; 1998:477-485.
6. The prevention and management of urinary tract infections among people with spinal cord injuries: National Institute on Disability and Rehabilitation Research Consensus Statement. J Am Paraplegia Soc. 1992;15:194-204.
7. Haley RW, Hooton TM, Culver DH, et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med. 1981;70:947-959.
8. Garibaldi RA, Burke JP, Dickman ML, Smith CB. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med. 1974;291:215-219.
9. Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol. 1985;121:159-167.
10. Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of blood stream infections in hospitalized patients. J Infect Dis. 1983;148:57-62.
11. Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol. 1984;132:494-498.
12. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584-602.
13. Givens CD, Wenzel RP. Catheter-associated urinary tract infections in surgical patients: a controlled study on the excess morbidity and costs. J Urol. 1980;124:646-648.
14. Green MS, Rubinstein E, Amit P. Estimating the effects of nosocomial infections on the length of hospitalizalion. J Infect Dis. 1982;145:667-672.
15. Platt R, Polk BF, Murdock B, Rosner B. Mortality associated with nosocomial urinary-tract infection. W Engl J Med. 1982;307:637-642.
16. Schaberg DR, Haley RW, Highsmith AK, Andersen RL, McGowan JE Jr. Nosocomial bacteriuria: a prospective study of case clustering and antimicrobial resistance. Ann Intern Med. 1980; 93:420-424.
17. Shapiro M, Simchen E, Izraeli S, Sacks TO. A multivariate analysis of risk factors for acquiring bacteriuria in patients with indwelling urinary catheters for longer than 24 hours. Infect Control. 1984;5:525-532.
18. Plan R, Polk BF, Murdock B, Rosner B. Risk factors for nosocomial urinary tract infection. Am J Epidemiol. 1986;124:977-985.
19. Johnson JR, Roberts PL, Olsen RJ, Moyer KA, Stamm WE. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis. 1990;162: 1145-1150.
20. Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal super infection. Am J Med. 1995; 98:349-356.
21. van der Wall E, Verkooyen RP, Mintjes de Groot J, et al. Prophylactic ciprofloxacin for catheter-associated urinary-tract infection. Lancet. 1992; 339:946-951.
22. Garibaldi RA, Burke JP, Britt MR, Miller MA, Smith CB. Meatal colonization and catheter-associated bacteriuria. N Engl J Med. 1980;303: 316-318.
23. Jerkeman M, Braconier JH.Bacteremic and nonbacteremic febrile urinary tract infection: a review of 168 hospital-treated patients. Infection. 1992;20:143-145.
24. Jain P, Parada JP, David A, Smith LG. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med. 1995; 155:1425-1429.
25. Wong ES. Guideline for prevention of catheter-associated urinary tract infections. Am J Infect Control. 1983;11:28-36.
26. Kunin CM. Can we build a better urinary catheter? N Engl J Med. 1988;319:365-366.
27. Sethia KK, Selkon JB, Berry AR, Turner CM, Kettlewell MG, Gough MH. Prospective randomized controlled trial of urethral versus suprapubic catheterization. Br J Surg. 1987;74: 624-625.
28. Schiotz HA, Malme PA, Tanbo TG. Urinary tract infections and asymptomatic bacteriuria after vaginal plastic surgery: a comparison of suprapubic and transurethral catheters. Acta Obstet Gynecol Scand. 1989;68:453-455.
29. O'Kelly TJ, Mathew A, Ross S, Munro A. Optimum method for urinary drainage in major abdominal surgery: a prospective randomized trial of suprapubic versus urethral catheterization. Br J Surg. 1995;82:1367-1368.
30. Andersen JT, Heisterberg L, Hebjorn S, et al. Suprapubic versus transurethral bladder drainage after colposuspension/vaginal repair. Acta Obstet Gynecol Scand. 1985;64:139-143.
31. Ichsan J, Hunt DR. Suprapubic catheters: a comparison of suprapubic versus urethral catheters in the treatment of acute urinary retention. Aust N Z J Surg. 1987;57:33-36.
32. Ratnaval CD, Renwick P, Farouk R, Monson JR, Lee PW. Suprapubic versus transurethral catheterisation of males undergoing pelvic colorectal surgery, Int J Colorectal Dis. 1996;11:177-179.
33. Morgan AF, Prasad B, Waldron DJ, O'Sullivan DC. Acute urinary retention: comparison of suprapubic and urethral catheterisation. Br J Urol. 1992;70:149-151.
34. Shapiro J, Hoffmann J, Jersky J. A comparison of suprapubic and transurethral drainage for postoperative urinary retention in general surgical patients. Acta Chir Scand. 1982;148:323-327.
35. Hirsh DD, Fainstein V, Musher DM. Do condom catheter collecting systems cause urinary tract infection? JAMA. 1979;242:340-341.
36. Ouslander JG, Greengold B, Chen S. Complications of chronic indwelling urinary catheters among male nursing home patients: a prospective study. J Urol. 1987;138:1191 -1195.
37. Ouslander JG, Greengold B, Chen S. External catheter use and urinary tract infections among incontinent male nursing home patients. J Am Geriatr Soc. 1987;35:1063-1070.
38. Zimakoff J, Stickler DJ, Pontoppidan B, Larsen SO. Bladder management and urinary tract infections in Danish hospitals, nursing homes, and home care: a national prevalence study. Infect Control Hosp Epidemiol. 1996;17: 215-221.
39. Warren JW. Urethral catheters, condom catheters, and nosocomial urinary tract infections. Infect Control Hosp Epidemiol. 1996;17:212-214.
40. Meares EM Jr. Current patterns in nosocomial urinary tract infections. Urology. 1991;37: 9-12.
41. Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med. 1966;274: 1155-1161.
42. Thornton GF, Andriole VT. Bacteriuria during indwelling catheter drainage, II: effect of a closed sterile drainage system. JAMA. 1970;214: 339-342.
43. Wolff G, Gradel E, Buchman B. Indwelling catheter and risk of urinary infection: a clinical investigation with a new closed-drainage system, Urol Res. 1976;4:15-18.
44. Platt R, Polk BF, Murdock B, Rosner B. Reduction of mortality associated with nosocomial urinary tract infection. Lancet. 1983;1:893-897.
45. Dudley MN, Barriere SL. Antimicrobial irrigations in the prevention and treatment of catheter-related urinary tract infections. Am J Hosp Pharm. 1981;38:59-65.
46. Bastable JR, Peel RN, Birch DM, Richards B. Continuous irrigation of the bladder after prostatectorny: its effect on post-prostatectomy infection. Br J Urol. 1977;49:689-693.
47. Kirk D, Dunn M, Bullock DW, Mitchell JP, Hobbs SJ. Hibitane bladder irrigation in the prevention of catheter-associated urinary infection. Br J Urol. 1979;51:528-531.
48. Warren JW, Platt R, Thomas RJ, Rosner B, Kass EH. Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med. 1978;299: 570-573.
49. Gelman ML. Antibiotic irrigation and catheter-associated urinary tract infections [editorial]. Nephron. 1980;25:259.
50. Southampton Infection Control Team. Evaluation of aseptic techniques and chlorhexidine on the rate of catheter-associated urinary-tract infection. Lancet. 1982;1:89-91.
51. Maizels M, Schaeffer AJ. Decreased incidence of bacteriuria associated with periodic instillations of hydrogen peroxide into the urethral catheter drainage bag. J Urol. 1980;123:841-845.
52. Sujka SK, Petrelli NJ, Herrera L. Incidence of urinary tract infections in patients requiring long-term catheterization after abdominoperineal resection for rectal carcinoma: does Betadine in the Foley drainage bag make a difference? Eur J Surg Oncol. 1987;13:341-343.
53. al Juburi AZ, Cicmanec J. New apparatus to reduce urinary drainage associated with urinary tract infections. Urology. 1989;33:97-101.
54. 2 prophylaxis of bacteriuria in patients with long-term indwelling Foley catheters: a randomized controlled study. Infect Control. 1985;6:263-266.
55. Thompson RL, Haley CE, Searcy MA, et al. Catheter-associated bacteriuria: failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems. JAMA. 1984;251:747-751.
56. Gillespie WA, Simpson RA, Jones JE, Nashef L, Teasdale C, Speller DC. Does the addition of disinfectant to urine drainage bags prevent infection in catheterised patients? Lancet. 1983;1: 1037-1039.
57. Burke JP, Garibaldi RA, Britt MR, Jacobson JA, Conli M, Ailing DW. Prevention of catheter-associated urinary tract infections: efficacy of daily meatal care regimens. Am J Med. 1981; 70:655-658.
58. Burke JP, Jacobson JA, Garibaldi RA, Conti MT, Ailing DW. Evaluation of daily meatal care with poly-antibiotic ointment in prevention of urinary catheter-associated bacteriuria. J Urol. 1983;129:331-334.
59. Lundeberg T. Prevention of catheter-associated urinary-tract infections by use of silver-impregnated catheters [letter]. Lancet. 1986;2:1031.
60. Schaefler AJ, Story KO, Johnson SM. Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria. J Urol. 1988;139:69-73.
61. Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol. 1990;65:379-381.
62. Liedberg H, Lundeberg T, Ekman P. Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria: an experimental and clinical study. Eur Urol. 1990;17:236-240.
63. Liedberg H, Lundeberg T. Prospective study of incidence of urinary tract infection in patients catheterized with bard hydrogel and silver-coated catheters or bard hydrogel-coated catheters [abstract]. J Urol. 1993;149:405A.
64. Takeuchi H, Hida S, Yoshida O, Ueda T. Clinical study on efficacy of a Foley catheter coated with silver-protein in prevention of urinary tract infections [in Japanese]. Hinyokika Kiyo. 1993; 39:293-298.
65. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of sliver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med. 1998;105: 236-241.
66. Kass EH. Chemotherapeutic and antibiotic drugs in the management of infections of the urinary tract. Am J Med. 1955;18:764-781.
67. Hustinx WN, Mintjes de Groot AJ, Verkooyen RP, Verbrugh HA. Impact of concurrent antimicrobial therapy on catheter-associated urinary tract infection. J Hosp Infect. 1991;18:45-56.
68. Vollaard EJ, Clasener HA, Zambon JV, Joosten HJ, van Griethuysen AJ. Prevention of catheter-associated gram-negative bacilluria with norfloxacin by selective decontamination of the bowel and high urinary concentration. J Antimicrob Chemother. 1989;23:915-922.
69. Verbrugh HA, Mintjes de Groot AJ, Andriesse R, Hamersma K, van Dijk A. Postoperative prophylaxis with norfloxacin in patients requiring bladder catheters. Eur J Clin Microbiol Infect Dis. 1988;7:490-494.
70. Little PJ, Pearson S, Peddie BA, Greenslade NF, Utley WL. Amoxicillin in the prevention of catheter-induced urinary infection. J Infect Dis. 1974; 129(suppl):S241-S242.
71. Catheter-acquired urinary tract infection [editorial]. Lancet. 1991;338:857-858.
72. Britt MR, Garibaldi RA, Miller WA, Hebertson RM, Burke JP. Antimicrobial prophylaxis for catheter-associated bacteriuria. Antimicrob Agents Chemother. 1977;11:240-243.
73. MountokalakisT, Skounakis M, Tselentis J. Short-term versus prolonged systemic antibiotic prophylaxis in patients treated with indwelling catheters. J Urol. 1985;134:506-508.
74. Platt R, Polk BF, Murdock B, Rosner B. Prevention of catheter-associated urinary tract infection: a cost-benefit analysis. Infect Control Hosp Epidemiol. 1989;10:60-64.
75. Schaeffer AJ. Catheter-associated bacteriuria. Urol Clin North Am. 1986;13:735-747.
76. Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med. 1991;91:655-715.
77. Nilsson S. Long-term treatment with methenamine hippurate in recurrent urinary tract infection. Acta Med Scand. 1975;198:81-85.
78. Norberg A, Norberg B, Parkhede U, Gippert H, Ekman R. The effect of short-term high-dose treatment with methenamine hippurate of urinary infection in geriatric patients with indwelling catheters, II: evaluation by means of a quantified urine sediment. Ups J Med Sci. 1979;84:75-82.
79. Norrman K, Wibell L. Treatment with methenamine hippurate in the patient with a catheter. J Int Med Res. 1976;4:115-117.
80. Norberg B, Norberg A, Parkhede U, Gippert H. Effect of short-term high-dose treatment with methenamine hippurate on urinary infection in geriatric patients with an indwelling catheter, IV: clinical evaluation. Eur J Clin Pharmacol. 1979; 15:357-361.
81. Nyr'en P, Runeberg L, Kostiala AI, Renkonen OV, Roine R. Prophylactic methenamine hippurate or nitrofurantoin in patients with an indwelling urinary catheter. Ann Clin Res. 1981; 13:16-21.
82. Vainrub B, Musher DM. Lack of effect of methenamine in suppression of, or prophylaxis against, chronic urinary infection. Antimicrob Agents Chemother. 1977;12:625-629.
83. Butler HK, Kunin CM. Evaluation of polymyxin catheter lubricant and impregnated catheters. J Urol. 1968;100:560-566.
84. Kunin CM, Finkelberg Z. Evaluation of an intraurethral lubricating catheter in prevention of catheter-induced urinary tract infections. J Urol. 1971; 106:928-930.
85. Weinberg SR, Sanford RS, Myman L, Bertoni G, Tanenbaum B. Evaluation of a catheter-care ointment. J Urol. 1972;108:89-90.
86. Cohen A. A microbiological comparison of a povidone-iodine lubricating gel and a control as catheter lubricants. J Hosp Infect. 1985;6: 155-161.
87. Huth TS, Burke JP, Larsen RA, Classen DC, Stevens LE. Randomized trial of meatal care with silver sulfadiazine cream for the prevention of catheter-associated bacteriuria. J Infect Dis. 1992; 165:14-18.
88. Cheng HJ. Manufacture and clinical employment of an antibiotic silicon-rubber catheter. Eur Urol. 1988;14:72-74.
89. Ruggieri MR, Hanno PM, Levin RM. Reduction of bacterial adherence to catheter surface with heparin. J Urol. 1987;138:423-426.
90. Monson T, Kunin CM. Evaluation of a polymer-coated indwelling catheter in prevention of infection. J Urol. 1974;111:220-222.
91. Nissenkorn I, Slutzker D. The intraurethral catheter: long-term follow-up in patients with urinary retention due to infravesical obstruction. Br J Urol. 1991;68:277-279.
92. Nissenkorn I, Richter S. A new self-retaining intraurethral device: an alternative to an indwelling catheter in patients with urinary retention due to intravesical obstruction. BrJ Urol. 1990;65: 197-200.
93. Nielsen KK, Klarskov P, Nordling J, Andersen JT, Holm HH. The intraprostatic spiral: new treatment for urinary retention. Br J Urol. 1990;65: 500-503.
94. Nissenkorn I. The intraurethral catheter: three years of experience. Eur Urol. 1993;24:27-30.
95. Slutzker D, Richter S, Lang R, Nissenkorn I. The use of a prostatic stent in high risk patients over 80 years old with benign prostatic hyperplasia and chronic retention. J Am Geriatr Soc. 1994; 42:1004-1005.
96. Nissenkorn I. A simple nonmetal stent for treatment of urethral strictures: a preliminary report. J Urol. 1995;154:1117-1118.
97. Gasser TC, Wisard M, Frei R. Oral tleroxacin prophylaxis in transurethral surgery. J Urol. 1996; 156:146-148.
98. Hall JC, Christiansen KJ, England P, et al. Antibiotic prophylaxis for patients undergoing transurethral resection of the prostate. Urology. 1996; 47:852-856.
99. Christensen MM. Antimicrobial prophylaxis in transurethral resection of the prostate: with special reference to preoperatively sterile urine. Scand J Urol Nephrol. 1991;25:169-174.
100. Amin M. Antibacterial prophylaxis in urology: a review. Am J Med. 1992;92:1145-1175.
101. Tolkoff-Rubin NE, Cosimi AB, Russell PS, Rubin RH. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis. 1982;4:614-618.
102. Fox BC, Sollinger HW, Beizer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med. 1990;89: 255-274.
103. Bierkens AF, Hendrikx AJ, Ezz el Din KE, et al. The value of antibiotic prophylaxis during extra-corporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment. Eur Urol. 1997;31:30-35.